| Dr Arthur Anthony Caire V, MD | |
|
5670 N Professional Park Dr Ste 100, Tucson, AZ 85704-7878 | |
| (520) 618-1010 | |
| (520) 784-7040 |
| Full Name | Dr Arthur Anthony Caire V |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 17 Years |
| Location | 5670 N Professional Park Dr Ste 100, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346474913 | NPI | - | NPPES |
| 081252 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 61537 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Medical Center | Tucson, AZ | Hospital |
| Oro Valley Hospital | Oro valley, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urological Associates Of Southern Arizona Pllc | 1658264551 | 4 |
| Arizona Urology Specialists Pllc | 5092863852 | 69 |
News Archive
Experts at Johns Hopkins have linked scientific evidence spanning more than 30 years to suggest an explanation for why testicular cancer patients like seven-time Tour de France winner Lance Armstrong survive far better than patients with other advanced cancers.
Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.
With most liver cancer caused by undetected or untreated hepatitis B or C viral infection, the 22,000 new cases of liver cancer that are diagnosed each year could be dramatically reduced if Congress took decisive action to close the funding gap for federal viral hepatitis education, screening, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) said today.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
The Hill reports that the "illegal immigration issue is emerging as the biggest threat to passing healthcare reform in the House." Members of the Congressional Hispanic Caucus are upset with a last-minute threat to "bolster the House bill's immigration restrictions to match those included in the Senate Finance bill."
› Verified 3 days ago
| Entity Name | Urological Associates Of Southern Arizona Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356410666 PECOS PAC ID: 1658264551 Enrollment ID: O20040204000930 |
News Archive
Experts at Johns Hopkins have linked scientific evidence spanning more than 30 years to suggest an explanation for why testicular cancer patients like seven-time Tour de France winner Lance Armstrong survive far better than patients with other advanced cancers.
Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.
With most liver cancer caused by undetected or untreated hepatitis B or C viral infection, the 22,000 new cases of liver cancer that are diagnosed each year could be dramatically reduced if Congress took decisive action to close the funding gap for federal viral hepatitis education, screening, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) said today.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
The Hill reports that the "illegal immigration issue is emerging as the biggest threat to passing healthcare reform in the House." Members of the Congressional Hispanic Caucus are upset with a last-minute threat to "bolster the House bill's immigration restrictions to match those included in the Senate Finance bill."
› Verified 3 days ago
| Entity Name | Arizona Institute Of Urology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260096 PECOS PAC ID: 1456445105 Enrollment ID: O20070926000096 |
News Archive
Experts at Johns Hopkins have linked scientific evidence spanning more than 30 years to suggest an explanation for why testicular cancer patients like seven-time Tour de France winner Lance Armstrong survive far better than patients with other advanced cancers.
Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.
With most liver cancer caused by undetected or untreated hepatitis B or C viral infection, the 22,000 new cases of liver cancer that are diagnosed each year could be dramatically reduced if Congress took decisive action to close the funding gap for federal viral hepatitis education, screening, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) said today.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
The Hill reports that the "illegal immigration issue is emerging as the biggest threat to passing healthcare reform in the House." Members of the Congressional Hispanic Caucus are upset with a last-minute threat to "bolster the House bill's immigration restrictions to match those included in the Senate Finance bill."
› Verified 3 days ago
| Entity Name | Arizona Urology Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740426485 PECOS PAC ID: 5092863852 Enrollment ID: O20090505000105 |
News Archive
Experts at Johns Hopkins have linked scientific evidence spanning more than 30 years to suggest an explanation for why testicular cancer patients like seven-time Tour de France winner Lance Armstrong survive far better than patients with other advanced cancers.
Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.
With most liver cancer caused by undetected or untreated hepatitis B or C viral infection, the 22,000 new cases of liver cancer that are diagnosed each year could be dramatically reduced if Congress took decisive action to close the funding gap for federal viral hepatitis education, screening, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) said today.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
The Hill reports that the "illegal immigration issue is emerging as the biggest threat to passing healthcare reform in the House." Members of the Congressional Hispanic Caucus are upset with a last-minute threat to "bolster the House bill's immigration restrictions to match those included in the Senate Finance bill."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arthur Anthony Caire V, MD 4811 E Grant Rd Ste 261, Tucson, AZ 85712-2776 Ph: (520) 618-1010 | Dr Arthur Anthony Caire V, MD 5670 N Professional Park Dr Ste 100, Tucson, AZ 85704-7878 Ph: (520) 618-1010 |
News Archive
Experts at Johns Hopkins have linked scientific evidence spanning more than 30 years to suggest an explanation for why testicular cancer patients like seven-time Tour de France winner Lance Armstrong survive far better than patients with other advanced cancers.
Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.
With most liver cancer caused by undetected or untreated hepatitis B or C viral infection, the 22,000 new cases of liver cancer that are diagnosed each year could be dramatically reduced if Congress took decisive action to close the funding gap for federal viral hepatitis education, screening, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) said today.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
The Hill reports that the "illegal immigration issue is emerging as the biggest threat to passing healthcare reform in the House." Members of the Congressional Hispanic Caucus are upset with a last-minute threat to "bolster the House bill's immigration restrictions to match those included in the Senate Finance bill."
› Verified 3 days ago
Richard A Ashley, M.D. Urology Medicare: Medicare Enrolled Practice Location: 5166 E. Glenn St., Tucson, AZ 85712 Phone: 520-795-5338 Fax: 520-795-5382 | |
Dr. Benjamin R Lee, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1501 N Campbell Ave, Division Urology, Box 245077, Tucson, AZ 85724 Phone: 520-626-6895 Fax: 520-626-4933 | |
Lauren Rittenberg, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 4790 S Calle Santa Cruz, Tucson, AZ 85714 Phone: 843-884-8045 | |
Matthew Gretzer, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1501 N Campbell Ave, Tucson, AZ 85724 Phone: 520-874-3500 | |
Martin Schiff, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1501 N Campbell Ave, Tucson, AZ 85724 Phone: 520-694-4032 Fax: 520-694-2404 | |
Dr. Ava Amalia Delu, MD Urology Medicare: Medicare Enrolled Practice Location: 1625 N Campbell Ave, Tucson, AZ 85719 Phone: 520-694-0111 | |
Dr. Anthony Chavez, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1106 N El Dorado Place, Tucson, AZ 85715 Phone: 520-296-7169 |